David Cronk

David Cronk joined Domainex in 2021 as Chief of Staff and has over 30 years’ drug discovery experience in CRO, large pharma and biotech companies. Previously he worked for 15 years at Charles River Laboratories as Science Director, High Throughput Screening Sciences. The primary focus of this role was to work closely with a range of globally distributed client organisations, to deliver HTS projects using cellular and biochemical assay formats, including screening using high throughput mass spectrometry. In this arena, David has worked on a diverse collection of targets, including GPCRs, ion channels, transporters, protein-protein interactions and enzymes. Prior to Charles River, David led the Molecular Pharmacology team at Ionix Pharmaceuticals, an analgesia-based biotech company and within GSK, and legacy companies, latterly leading the Ion Channel HTS team.

David also has a keen interest in compound management and technologies applicable to in vitro biological assays which support hit finding and downstream chemical optimisation.